precision diagnostics.
Look SPOT is an asy‑to‑use and fast diagnostic tool using AI to test for the presence of an array of ailments.
As Us For More Information
LooK SPOT Disease Diagnostic System
The LookSpot has been developed as a Rapid COVID‑19 antigen testing devices and sold in countries around the world, with the assistance of the Canadian Trade Commissioner Service (TCS). In Europe, the company secured the CE Mark, which certifies that the product meets EU health and safety requirements. Laipac took advantage of the European market through the Canada–European Union (EU) Comprehensive Economic and Trade Agreement (CETA).
Patients can download the LooK PASS App from Apple or Google stores to scan the LooK COVID-19 antigen cassette before the test and receive the test results on their phones within 5 to 8 minutes. Negative test results generate a QR code on the app used as a Day Pass to enter the facility or transportation. Laipac also provides API for integration with health & travel applications to control the widespread of the SARS-CoV-2 virus.
Look SPOT V2
The company then developed an easy‑to‑use and fast diagnostic tool using AI to test for the presence of things like malaria, dengue fever, Ebola and sexually transmitted diseases. Some examples of diagnostics testing with LookSPOT Disease Diagnostic System is as follows.